rheumatoid arthritis
Metabolon, SERA Partner on Research Into Metabolomic Biomarkers for Rheumatoid Arthritis
The project will combine Metabolon's metabolomics platform with SERA's patient samples to study molecular mechanisms of RA development and progression.
Oxford BioDynamics, King's College London to Develop Biomarkers for Rheumatoid Arthritis Prevention
Oxford BioDynamics will use its EpiSwitch 3D genomics platform to develop blood-based biomarkers of disease progression and response to the drug Orencia.
Systemic Sclerosis Study Highlights Immune-Related Genetic Risk Loci
Researchers found six new systemic sclerosis risk variants in a Japanese GWAS and cross-ancestry meta-analysis, including B cell-related regulatory variants.
The company showed early data establishing a rheumatoid arthritis-specific expression signature and is enrolling patients into a larger study.
Quest Diagnostics, Scipher Medicine Collaborate on Rheumatoid Arthritis Test
Quest will provide RNA extraction and sequencing services for Scipher's PrismRA test, a blood-based molecular test for predicting patient response to TNF inhibitors.